EUVIMEDEUVIMED entdecken
Historischer BeitragOpen Access · CC BY 4.0

The commercial roots of the genomic commons

Steve Sturdy iD

Social Studies of Science · 2025

DOI: 10.1177/03063127241310122 ↗

Kurz gefasst

Historischer Beitrag in der Zeitschrift Social Studies of Science, 2025. Verfasst von Steve Sturdy. Beteiligte Einrichtung: Science, Technology and Innovation Studies, The University of Edinburgh, Edinburgh, Scotland, UK. Hauptthemen laut MEDLINE: Genomics, Intellectual Property, Drug Industry. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 141 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Accounts of the origins of the genomic commons typically focus on the development of public repositories and data-sharing agreements. This article tells a different story. During the 1990s in the United States, efforts of private companies to prevent the patenting of certain kinds of DNA sequences were essentially a conservative response to shifts in the sociotechnical constitution of the pharmaceutical innovation system, and to the operation of intellectual property as one of the key knowledge control regimes that regulate that system. In this context, the idea of ‘the commons’ was rehabilitated from earlier tragic theorizations to argue that industry’s ability to deliver new pharmaceutical products would be better served if certain kinds of intellectual property were left in the public domain. The genomic commons is not a neutral space of disinterested scientific research that naturally aligns with some abstract ‘public good’, but is part of an innovation system that has evolved to serve the interests of a range of stakeholders, among which the big pharmaceutical companies enjoy a dominant position.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GenomicsIntellectual PropertyDrug IndustryUnited StatesHistory, 20th CenturyPatents as TopicHumans

Stichwörter der Autor:innen

biotechnologycommonsgenomicsinnovation systemsintellectual property

Autor:innen und Institutionen

  • Science, Technology and Innovation Studies, The University of Edinburgh, Edinburgh, Scotland, UK.

ORCID-Profile: Steve Sturdy

Förderung

  • Wellcome Trust

Zitieren

APA

Sturdy, S. (2025). The commercial roots of the genomic commons. Social Studies of Science. https://doi.org/10.1177/03063127241310122

Vancouver

Sturdy S. The commercial roots of the genomic commons. Social Studies of Science. 2025. doi:10.1177/03063127241310122

BibTeX
@article{Sturdy2025,
  author = {Sturdy, Steve},
  title = {The commercial roots of the genomic commons},
  journal = {Social Studies of Science},
  year = {2025},
  doi = {10.1177/03063127241310122}
}
Kostenlos starten →